Wuchereria bancrofti infection is associated with progression to clinical visceral leishmaniasis in VL- endemic areas in Muzaffarpur, Bihar, India
-
Published:2023-10-30
Issue:10
Volume:17
Page:e0011729
-
ISSN:1935-2735
-
Container-title:PLOS Neglected Tropical Diseases
-
language:en
-
Short-container-title:PLoS Negl Trop Dis
Author:
Singh Abhishek Kumar,
de Gooyer TanythORCID,
Singh Om Prakash,
Pandey Sundaram,
Neyaz Aziza,
Cloots Kristien,
Kansal Sangeeta,
Malaviya Paritosh,
Rai Madhukar,
Nylén Susanne,
Chakravarty Jaya,
Hasker Epco,
Sundar ShyamORCID
Abstract
Background
Co-endemicity of neglected tropical diseases (NTDs) necessitates that these diseases should be considered concomitantly to understand the relationship between pathology and to support disease management and control programs. The aims of the study were to assess the prevalence of filarial infection in asymptomatic Leishmania donovani infected individuals and the correlation of Wuchereria bancrofti infection with progression to clinical visceral leishmaniasis (VL) in Bihar, India.
Methodology/Principal findings
Within the Muzaffarpur-TMRC Health and Demographic Surveillance System (HDSS) area, a cohort of Leishmania seropositive (n = 476) or seronegative individuals (n = 1130) were sampled annually for three years for filarial infection and followed for progression to clinical VL. To corroborate the results from the cohort study, we also used a retrospective case-control study of 36 VL cases and 71 controls selected from a subset of the HDSS population to investigate the relationship between progression to clinical VL and the prevalence of filarial infection at baseline. Our findings suggest a higher probability of progression to clinical VL in individuals with a history of filarial infection: in both the cohort and case-control studies, progression to clinical VL was higher among filaria infected individuals (RR = 2.57, p = 0.056, and OR = 2.52, p = 0.046 respectively).
Conclusion
This study describes that progression to clinical VL disease is associated with serological evidence of prior infection with W. bancrofti. The integration of disease programs for Leishmania and lymphatic filariasis extend beyond the relationship of sequential or co-infection with disease burden. To ensure elimination targets can be reached and sustained, we suggest areas of co-endemicity would benefit from overlapping vector control activities, health system networks and surveillance infrastructure.
Funder
National Institute of Health (NIH) - TMRC
Publisher
Public Library of Science (PLoS)
Subject
Infectious Diseases,Public Health, Environmental and Occupational Health
Reference52 articles.
1. Deleting the ’neglect’ from two neglected tropical diseases in India;L. Kant;Indian J Med Res,2016
2. Visceral leishmaniasis elimination in India: progress and the road ahead;OP Singh;Expert Rev Anti Infect Ther,2022
3. National Center for Vector Borne Diseases Control (NCVBDC) Ministry of Health & Family Welfare Government of India. Filaria Endemic Districts. [17 January 2023]. https://nvbdcp.gov.in/index4.php?lang=1&level=0&linkid=453&lid=3733.
4. Introduction of triple-drug therapy for accelerating lymphatic filariasis elimination in India: Lessons learned;B Tripathi;American Journal of Tropical Medicine and Hygiene,2022
5. Asymptomatic Leishmania infection: a new challenge for Leishmania control;OP Singh;Clin Infect Dis,2014